NCT00403260View on ClinicalTrials.gov

Pyronaridine - Artesunate (3:1) Versus Mefloquine Plus Artesunate in Plasmodium Falciparum Malaria Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

1,271

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

October 31, 2008

Study Completion Date

December 31, 2008

Conditions
Falciparum Malaria
Interventions
DRUG

Pyronaridine - artesunate

once a day for 3 days

DRUG

Mefloquine plus artesunate

once a day for 3 days

Trial Locations (9)

01 BP390

RAOTAP2/Centre Muraz, Bobo-Dioulasso

Unknown

Pailin Referral Hospital, Pailin

Institut Pasteur, Abidjan

Wentlock District Hospital, Mangalore

Bagamoyo Research and Training Centre of Ifakara Health Institute, Bagamoyo

MaeLamad District Hospital, Mae Ramat

MaeSod General Hospital, Mae Sot

NIMPE, Hanoi

Choray Hospital, Dak O, Ho Chi Minh City

All Listed Sponsors
collaborator

Shin Poong Pharmaceuticals

INDUSTRY

lead

Medicines for Malaria Venture

OTHER

NCT00403260 - Pyronaridine - Artesunate (3:1) Versus Mefloquine Plus Artesunate in Plasmodium Falciparum Malaria Patients | Biotech Hunter | Biotech Hunter